BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/84/0.1/20.12.24 | Market Closed - Boerse Frankfurt Warrants 01:45:28 2024-07-12 pm EDT | ||
| 0.31 EUR | +14.81% |
|
| Current month | +3.33% | ||
| 1 month | -29.55% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 0.31 | +14.81% |
| 24-07-11 | 0.27 | -3.57% |
| 24-07-10 | 0.28 | -3.45% |
| 24-07-09 | 0.29 | -6.45% |
| 24-07-08 | 0.31 | -3.13% |
Real-time Boerse Frankfurt Warrants
Last update July 12, 2024 at 01:45 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD3R88 |
| ISIN | DE000VD3R884 |
| Date issued | 2024-04-09 |
| Strike | 84 $ |
| Maturity | 2024-12-20 (160 Days) |
| Parity | 10 : 1 |
| Emission price | 0.45 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.67 € |
|---|---|
| Lowest since issue | 0.27 € |
| Spread | 0.01 € |
| Spread % | 2.94% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.99
USD
Average target price
96.16
USD
Spread / Average Target
+5.69%
- Stock Market
- Warrants
- Warrant
